Log in
Enquire now
‌

US Patent 11129872 Methods of making and using soluble MHC molecules

Patent 11129872 was granted and assigned to Kite Pharma, Inc. on September, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Kite Pharma, Inc.
Current Assignee
‌
Kite Pharma, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11129872
Date of Patent
September 28, 2021
Patent Application Number
20170811
Date Filed
August 11, 2017
Patent abstract

Provided herein are methods of making a detectably-labeled, soluble MHC molecule that can be used in a novel Kon-rate assay and an improved TCR ligand koff-rate assay.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11129872 Methods of making and using soluble MHC molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.